Reduced price!
NexGard Spectra View larger

NexGard Spectra (2-3.5 kg)

New product

COMPOSITION: Afoxolaner + milbemycin oxime

More details

12,47 € tax incl.

-10%

13,85 € tax incl.

Add to wishlist

COMPOSITION: Afoxolaner + milbemycin oxime

CONTRAINDICATIONS: Do not use in case of hypersensitivity to the active substances or to any of the excipients.

ADVERSE REACTIONS: In clinical studies, no serious adverse reactions were attributed to the combination of afoxolaner with milbemycin oxime. Infrequently, adverse reactions were observed such as: vomiting, diarrhea, lack of energy, decreased appetite and itching. These reactions were in general of spontaneous resolution and of short duration. The frequency of adverse reactions should be classified according to the following groups:

- Very frequently: more than 1 animal per 10 presents adverse reactions during a treatment

- Frequently: more than 1 but less than 10 animals per 100

- Infrequently: more than 1 but less than 10 animals per 1,000

- Rarely: more than 1 but less than 10 animals per 10,000

- Very rarely: less than 1 animal per 10,000, including isolated cases If you observe any serious or undesirable effects in this leaflet, please inform your veterinarian.

DESTINATION SPECIES: Dogs POSOLOGY FOR EACH SPECIES,

METHOD AND ROUTE OF ADMINISTRATION: Oral route. Dose: The veterinary medicinal product must be administered as follows:

- 2-3.5 kg: 1 NexGard sprectra 9mg / 2mg

- 3.5-7.5 kg: 1 NexGard spectra 19 mg / 4 mg

- 7.5-15 kg: 1 NexGard spectra 38 mg / 8 mg

- 15-30 kg: 1 NexGard spectra 75 mg / 15 mg

- 30-60 kg: 1 NexGard spectra 150 mg / 30 mg

For dogs weighing more than 60 kg, use the appropriate combination of chewable tablets. They cannot be split.

Method of administration: The tablets are chewable and appetizing for most dogs. If the dog does not accept the tablets directly, they can be administered with food.

Treatment guideline: the treatment guideline should be based on the veterinary diagnosis and the local epidemiological situation. NEXGARD SPECTRA can be used as part of the seasonal treatment of fleas and ticks (replacing a drug authorized for the treatment of fleas and ticks only) in dogs in which both infestations by gastrointestinal worms have been diagnosed. A single treatment is effective for gastrointestinal worms. The effectiveness of the treatment against infestations by fleas and ticks lasts one month. Subsequent treatments may be indicated during the flea and / or tick season. Ask your veterinarian how to continue treating fleas and ticks.

Dirofilariosis: NEXGARD SPPECTRA kills the larvae of Dirofilaria inmitis up to one month after its transmission by mosquitoes. Therefore, the medication should be administered at regular monthly intervals during the time of the year when the mosquitoes are present, beginning the month following the first expected exposure to them.The treatment should be continued up to 1 month after the last exposure to mosquitoes . To establish a treatment routine, it is recommended that it be used on the same day or the same date of each month. When replacing another preventive medication for dirofilaria in a dirofilaria prevention program, the first treatment with NEXGARD SPECTRA should start on the date on which the other medication would have to be administered. Dogs that live in endemic areas of the dirofilaria (where dirofilariosis is present), op that s that has traveled to endemic areas, may be infected by adult dirofilarias. No therapeutic effect has been established against Dirofilaria inmitis adult. Therefore, it is recommended that in all dogs 8 months of age or older that live in endemic areas of dirofilaria, a test is carried out to verify the existence of infestation by a dirofilaria dulta before being treated with the medicine for the prevention of Dirofilaria.

INSTRUCTIONS FOR A CORRECT ADMINISTRATION: The tablets are chewable and appetizing for most dogs. If the dog does not accept the tablets directly, they can be administered with food.

WAITING TIME: Not applicable.

SPECIAL PRESERVATION PRECAUTIONS: Keep out of the sight and reach of children. Keep the blister in the box in order to protect from light. Do not use this veterinary medicinal product after the expiration date on the box after CAD.

SPECIAL WARNINGS: Special warnings for each target species: fleas and ticks need to start feeding once attached to the host to be exposed to the afoxolaer substance; therefore the risk of transmission of diseases by fleas and ticks cannot be ruled out. Resistance of the parasite to an antiparasitic of a particular class may develop after repeated and frequent use of a drug of that class. Therefore, the use of this medicine should be adapted to each individual case.

No customer reviews for the moment.

Write a review

NexGard Spectra (2-3.5 kg)

NexGard Spectra (2-3.5 kg)

COMPOSITION: Afoxolaner + milbemycin oxime

4 other products in the same category: